Who is sponsoring NCT04666857?

NCT04666857 is sponsored by University Children's Hospital, Zurich.

What drugs are being tested in NCT04666857?

Interventions in NCT04666857: early motor intervention.

What condition does NCT04666857 study?

NCT04666857 studies Congenital Heart Disease in Children.

Is NCT04666857 still recruiting?

NCT04666857 is currently completed. Last updated 21 September 2023.

Last reviewed 2023-09-21 · How we verify

NCT04666857

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Family Centred Early Intervention of Infants With Congenital Heart Disease

Completed NA Last updated 21 September 2023

What this trial tests

NA trial testing early motor intervention in Congenital Heart Disease in Children in 10 participants. Completed in 20 February 2023.

Timeline

31 May 2021

Primary endpoint
19 December 2022

20 February 2023

Quick facts

Lead sponsor	University Children's Hospital, Zurich
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	10
Start date	31 May 2021
Primary completion	19 December 2022
Estimated completion	20 February 2023
Sites	1 location across Switzerland

Drugs / interventions tested

early motor intervention

Conditions studied

Congenital Heart Disease in Children — all drugs for Congenital Heart Disease in Children →

Sponsor

University Children's Hospital, Zurich

Who can join

Adults 2 Months to 12 Months, any sex, with Congenital Heart Disease in Children. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In this study the investigators aim to test the feasibility for therapists and acceptability to parents of an early motor intervention for infants with congenital heart disease (CHD) after open heart surgery. This intervention will be compared to the standard care of treatment that is recommended for infants with congenital heart disease at the University Children Hospital Zurich.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

The molecular mechanisms of cardiac development and related diseases.
Li Y, Du J, Deng S, Liu B, et al · · 2024 · cited 53× · PMID 39715759 · DOI 10.1038/s41392-024-02069-8

Verify or expand the search:

Other recruiting trials for Congenital Heart Disease in Children

Currently open trials in the same condition.

NCT07029230 — Blood Based Assessment of sST2, Taken During and After Surgery, for Pediatric Patients With Heart Defects to Predict Hea · recruiting
NCT07414251 — Evaluation of Preoperative Preparation in Children Undergoing Cardiac Surgery or Catheterization · recruiting
NCT06383546 — Artificial Intelligence-enabled ECG Detection of Congenital Heart Disease in Children: a Novel Diagnostic Tool · recruiting
NCT05647161 — BAX602 in Preventing the Adhesion Around Great Cardiac Vessels in Pediatric Patients With Congenital Heart Disease Under · NA · active not recruiting
NCT05268094 — Comparison of Methods of Pulmonary Blood Flow Augmentation in Neonates: Shunt Versus Stent (The COMPASS Trial) · NA · active not recruiting

Other University Children's Hospital, Zurich trials

Trials by the same sponsor.

NCT07415577 — The Use of Cultured (Dermal) Epithelial Autografts in Severely Burned Patients · not yet recruiting
NCT06852313 — Save the Ovaries - Surgical Management of Simple Ovarian Cysts in Children and Adolescents · NA · recruiting
NCT07368166 — Development of the PTSD-iMPACT to Measure PTSD-Related Functional Impairment in Children and Adolescents - A Validation · recruiting
NCT06950047 — PediLoc® Blade Plate in Distal Femoral Osteotomies · completed
NCT05971264 — Comparison of Bladder Pressure Versus Regional Intestinal Tissue Oxygenation in Infants · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04666857 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University Children's Hospital, Zurich
Last refreshed: 21 September 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04666857.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing